Medivir Ser B Sek5 (MVRBF) 10.4500 $MVRBF Medivir

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Medivir Ser B Sek5 (MVRBF) 10.4500 $MVRBF

Medivir announces the first cancer project derived from its in-house nucleotide platform
Business Wire - Tue Jun 30, 1:47AM CDT
Medivir AB (Nasdaq Stockholm: MVIR) today announces a new discovery project for a cancer indication, a liver targeted nucleotide prodrug for the treatment of hepatocellular carcinoma (HCC). The project is based on the company's expertise in nucleoside and nucleotide science and is the first cancer project to emerge from its in-house discovery efforts in oncology that were announced in 2014.

Medivir reorganises R&D structure and optimises resources through a partnership with GVK BIO
M2 - Wed Jun 17, 3:45AM CDT
Medivir AB (STO:MVIRB), a research based pharmaceutical company with a research focus on infectious diseases and oncology, announced on Tuesday a reorganisation within its Discovery Research department, increasing its focus within the core areas of oncology and infectious diseases, as well as a partnership with GVK Biosciences Private Ltd. (GVK BIO) of Hyderabad in India.

Bone Metastasis Pipeline Review, H1 2015
M2 - Thu Jun 11, 10:16AM CDT
Research and Markets (http://www.researchandmarkets.com/research/tvrmb7/bone_metastasis) has announced the addition of the "Bone Metastasis - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Bone Metastasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Bone Metastasis and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - Ablynx NV - Alethia Biotherapeutics Inc. - Amgen Inc. - Amura Holdings Ltd. - Bayer AG - ChemoCentryx, Inc. - Debiopharm International S.A. - Deciphera Pharmaceuticals, LLC - Digna Biotech, S.L. - Medivir AB - Merrion Pharmaceuticals Plc - Osteologix Holdings Plc. - R-Pharm - Sigma-Tau S.p.A. For more information visit http://www.researchandmarkets.com/research/tv...metastasis
CCXI: 8.60 (+0.19), AMGN: 154.10 (+2.79)

Medivir: Medivir's CEO increases his shareholding in the company
Business Wire - Tue May 12, 6:11AM CDT
Regulatory News:

Medivir posts profit of SEK66.7m in Q1 2015
M2 - Wed May 06, 7:04AM CDT
Medivir AB (STO: MVIR) on Tuesday reported profit after tax of SEK66.7m, or diluted EPS of SEK2.27, for the first quarter of 2015, from January 2015 to March 2015.
MVIR: ()

Medivir's Board of Directors Has Resolved to Repurchase Own Shares
Business Wire - Wed May 06, 1:58AM CDT
Regulatory News:

Medivir AB - Interim Report January - March 2015
Business Wire - Tue May 05, 3:21AM CDT
Regulatory News:
MVIR: ()

Medivir: Positive preclinical antiviral and safety profile of MIV-802 supports continued development
Business Wire - Thu Apr 23, 7:11AM CDT
Regulatory News:

Medivir: Data from OPTIMIST trials show SVR12 rates of 97 percent in HCV patients without cirrhosis and 84 percent in HCV patients with cirrhosis
Business Wire - Thu Apr 23, 3:39AM CDT
Regulatory News:

Medivir earns €13.8M Olysio royalty in Q1
Seeking Alpha - at Seeking Alpha - Tue Apr 14, 8:06AM CDT


Medivir: OLYSIO(R) sales during the first quarter 2015
Business Wire - Tue Apr 14, 7:08AM CDT
Regulatory News:

Medivir and Cancer Research Technology Collaborate to Develop New Class of Cancer Drugs
Business Wire - Mon Apr 13, 1:36AM CDT
Regulatory News:

Medivir: Annual Report 2014
Business Wire - Tue Apr 07, 1:50AM CDT
Regulatory News:

Notice of Annual General Meeting of Medivir AB (publ)
Business Wire - Wed Apr 01, 1:49AM CDT
Regulatory News:

Medivir: New Data on Simeprevir Presented at the Conference of the Asian Pacific Association for the Study of the Liver
Business Wire - Mon Mar 16, 2:41AM CDT
Regulatory News:

Medivir Capital Markets Meeting on 26 March 2015
Business Wire - Thu Mar 12, 2:43AM CDT
Regulatory News:

Medivir: New Members of Medivir's Management Group
Business Wire - Mon Mar 02, 7:35AM CST
Regulatory News:
MVIR: ()

Medivir announces proposal for new board of directors by nomination committee ahead of AGM 2015
M2 - Thu Feb 19, 5:47AM CST
Medivir AB (OMX: MVIR), a research based pharmaceutical company with a research focus on infectious diseases and oncology, announced on Wednesday that the company's nomination committee's proposal for a new board of directors will be submitted to the 2015 Annual General Meeting.
MVIR: ()

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 12

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 12

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 11

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 16

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 12

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 14

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Women Through the Gettysburg Salon Experience

Updated Category News Views 116

Reimagining Women's Spaces Through the Gettysburg Salon The Gettysburg Salon is a vibrant platform where women can express themselves creatively and engage in thought-provoking dialogues. This initiative began with three passionate individuals who envisioned a safe space for women to explore their identities, aspirations, and challenges through art and conversation. In a...

Continue Reading
Transforming Off-Road Adventures: Upfit UTV and OMI Innovation

Updated Category News Views 165

Transforming Off-Road Adventures: Upfit UTV and OMI Innovation Upfit UTV, a subsidiary of Fox Factory known for customizing high-performance vehicles, has joined forces with OMI, a leader in electric powertrain engineering. Together, they are redefining off-road adventures with their groundbreaking Fusion-Drive technology. This innovation not only elevates performance but...

Continue Reading
Investor Alert: AstraZeneca Faces Class Action Lawsuit Under SEC Laws

Updated Category News Views 278

Investor Alert Regarding AstraZeneca Securities Class Action Kahn Swick & Foti, LLC, founded by former Attorney General Charles C. Foti, Jr., is highlighting crucial information for investors in AstraZeneca PLC (NASDAQ: AZN) who may have incurred losses exceeding $100,000. The firm reminds those affected that they need to file lead plaintiff applications for their class...

Continue Reading
Important Class Action for GSK plc Investors: Know Your Rights

Updated Category News Views 208

GSK Faces Class Action Lawsuit: Key Information for Investors Levi & Korsinsky, LLP has announced a class action securities lawsuit involving GSK plc, a well-known pharmaceutical company traded on the NYSE under the ticker GSK. This lawsuit is particularly significant for investors who have been adversely affected during a specified period concerning the securities of...

Continue Reading
Denny’s Fundraiser for No Kid Hungry: Making a Difference

Updated Category News Views 435

Denny’s Annual Fundraiser for No Kid Hungry Returns Denny’s is excited to bring back its annual in-restaurant fundraiser to support No Kid Hungry, a national initiative focused on ending childhood hunger in the United States. This campaign will run for a designated period, allowing Denny's restaurants to make a meaningful difference by ensuring that children have...

Continue Reading